| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 2e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.0008 |